93 related articles for article (PubMed ID: 3028278)
1. [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Ohmura K; Suzuki M; Takao ; Matsuo SK; Ohtsuka Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):523-6. PubMed ID: 3028278
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Kitamura T; Maruyama T; Nakamura H; Hayashi K; Shigehira M; Iwaki Y; Okamoto T; Ishikawa T; Ishinoda Y; Kisanuki H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1467-71. PubMed ID: 2167633
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
Inoue Y; Nasu H; Nakamura J; Arakawa H; Masamune O; Yamada N; Furuya M; Ookubo M; Mukojima T; Koizumi R
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3567-72. PubMed ID: 2510604
[TBL] [Abstract][Full Text] [Related]
4. [Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas].
Kojima J; Kamata T; Monna T
Gan To Kagaku Ryoho; 1992 May; 19(5):637-46. PubMed ID: 1316100
[TBL] [Abstract][Full Text] [Related]
5. [Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
Goto Y; Toyota T; Asaki S; Satoh J; Kikuchi T; Koizumi M; Ohkubo T; Nomura N; Mochizuki F; Taima T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2227-33. PubMed ID: 2500068
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
[TBL] [Abstract][Full Text] [Related]
7. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
[TBL] [Abstract][Full Text] [Related]
8. [Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gallbladder and Pancreas].
Kojima J; Kamata T; Monna T
Gan To Kagaku Ryoho; 1990 May; 17(5):1005-13. PubMed ID: 2159264
[TBL] [Abstract][Full Text] [Related]
9. [Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric carcinoma. Hokuriku Cisplatin Round-table Conference].
Matsuki N; Sakuma H; Sawa T; Yagi M; Hagino S; Katayama K; Note M; Uogishi M; Ueno K; Sawazaki K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):655-9. PubMed ID: 3128180
[TBL] [Abstract][Full Text] [Related]
10. [UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Sasai T; Kurihara M; Kubo Y; Nakano S; Kamano T; Taguchi S; Fukuyama E; Suwa T; Miyoshi K; Oda K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):141-6. PubMed ID: 3122666
[TBL] [Abstract][Full Text] [Related]
11. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
12. [Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
Sugimachi K; Okamura T; Furusawa M; Saku M; Noda S; Matsusaka T; Teraoka H; Toda T; Oka N; Inokuchi K
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2953-7. PubMed ID: 3140734
[TBL] [Abstract][Full Text] [Related]
13. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
[TBL] [Abstract][Full Text] [Related]
14. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
[TBL] [Abstract][Full Text] [Related]
15. [Maintenance chemotherapy by UFT after trans-arterial embolization for hepatocellular carcinoma].
Nakanishi T; Kawakami H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1589-95. PubMed ID: 3015034
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combination of UFT and MMC (UFT-M therapy) on human colonic cancer xenotransplanted into nude mice].
Takahashi Y; Kikuchi R; Ueno M; Mai M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1345-7. PubMed ID: 3107480
[No Abstract] [Full Text] [Related]
17. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
18. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Motohara T; Ozawa Z; Morita S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
[TBL] [Abstract][Full Text] [Related]
19. [UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Suga S; Kimura K; Yokoyama Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):769-74. PubMed ID: 6424582
[TBL] [Abstract][Full Text] [Related]
20. [The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Yamada R; Tsuda M; Sato M; Nakayama T; Nishioka S; Yataka I; Nakamura K; Onoyama Y; Kanno T; Nakatsuka H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2621-6. PubMed ID: 2843130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
